Clinical Implementation of Adaptive Hypofractionated Bladder Radiotherapy for Improvement in Normal Tissue Irradiation-Reference-Cited by-同舟云学术

Clinical Implementation of Adaptive Hypofractionated Bladder Radiotherapy for Improvement in Normal Tissue Irradiation

Published:2013-09 Issue:9 Volume:25 Page:549-556
ISSN:0936-6555
Container-title:Clinical Oncology
language:en
Short-container-title:Clinical Oncology

Author:

McDonald F.,Lalondrelle S.,Taylor H.,Warren-Oseni K.,Khoo V.,McNair H.A.,Harris V.,Hafeez S.,Hansen V.N.,Thomas K.,Jones K.,Dearnaley D.,Horwich A.,Huddart R.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology

Reference23 articles.

1. Impact of changes in bladder and rectal filling volume on organ motion and dose distribution of the bladder in radiotherapy for urinary bladder cancer;Fokdal;Int J Radiat Oncol Biol Phys,2004

2. Tumor motion and deformation during external radiotherapy of bladder cancer;Lotz;Int J Radiat Oncol Biol Phys,2006

3. A model to predict bladder shapes from changes in bladder and rectal filling;Lotz;Med Phys,2004

4. Three-dimensional analysis of delineation errors, setup errors, and organ motion during radiotherapy of bladder cancer;Meijer;Int J Radiat Oncol Biol Phys,2003

5. CT-guided intensity-modulated radiotherapy for bladder cancer: isocentre shifts, margins and their impact on target dose;Redpath;Radiother Oncol,2006

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Future of Multidisciplinary Team in the Context of Adaptive Therapy;Seminars in Radiation Oncology;2024-10

2. Adaptive radiotherapy for muscle invasive bladder cancer: a retrospective audit of two bladder filling protocols;Radiation Oncology;2024-07-19

3. Bladder Tumor-Focused Adaptive Radiation Therapy: Clinical Outcomes of a Phase I Dose Escalation Study;International Journal of Radiation Oncology*Biology*Physics;2024-07

4. Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524—A Phase 1/2 Trial of Paclitaxel + Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily Irradiation;European Urology Oncology;2024-02

5. Empirical analysis of a plan‐of‐the‐day strategy to approximate daily online reoptimization for prostate CBCT‐guided adaptive radiotherapy;Journal of Applied Clinical Medical Physics;2023-11-29